James J. Dignam

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert, James J. Dignam, Terri S. Armstrong et al. · New England Journal of Medicine · 2014 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

Bernard Fisher, James J. Dignam, Norman Wolmark et al. · The Lancet · 1999 · 1K citations

Medicine, Gynecology, Oncology +12

Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality

Robert T. Dess, Holly Hartman, Brandon A. Mahal et al. · JAMA Oncology · 2019 · 409 citations · Full text

Medicine, Oncology, Urology +17

Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer

James J. Dignam, Blasé N. Polite, Greg Yothers et al. · JNCI Journal of the National Cancer Institute · 2006 · 331 citations

Medicine, Oncology, Surgery +17

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.

Bernard Fisher, James J. Dignam, Eleftherios P. Mamounas et al. · Journal of Clinical Oncology · 1996 · 235 citations

Medicine, Oncology, Pharmacology +17